Journal article
Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients
Abstract
BACKGROUND: Atherosclerosis is a chronic inflammatory process, and myeloperoxidase (MPO) seems to contribute directly to the pathogenesis of acute coronary syndrome (ACS).
OBJECTIVE: To compare MPO levels among the patients with stable and unstable ischemic heart disease and to evaluate their independent prognostic value for cardiovascular events.
Authors
Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
Journal
Coronary Artery Disease, Vol. 21, No. 3, pp. 129–136
Publisher
Wolters Kluwer
Publication Date
5 2010
DOI
10.1097/mca.0b013e328333f50d
ISSN
0954-6928
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
Acute Coronary SyndromeAgedAngina PectorisAngina, UnstableArrhythmias, CardiacBiomarkersC-Reactive ProteinChi-Square DistributionCoronary Artery DiseaseFemaleHeart FailureHumansInflammation MediatorsKaplan-Meier EstimateMaleMiddle AgedOdds RatioPeroxidasePrognosisProportional Hazards ModelsProspective StudiesRecurrenceRisk AssessmentRisk FactorsTime FactorsUp-Regulation